[1] Suyama S,Nakaguchi T,Kawakami K,et al. Computed tomography analysis of causes of local failure in radiotherapy for cervical carcinoma[J].Cancer,1998,83(9):1956-1965.DOI:10.1002/(SICI)1097-0142(19981101)83:9<1956::AID-CNCR11>3.0.CO;2-I.
[2] Low DA,Grigsby PW,Dempsey JF,et al. Applicator-guided intensity-modulated radiation therapy[J].Int J Radiat Oncol Biol Phys,2002,52(5):1400-1406.DOI:10.1016/S0360-3016(01)02798-5.
[3] Wahab SH,Malyapa RS,Mutic S,et al. A treatment planning study comparing HDR and AGIMRT for cervical cancer[J].Med Phys,2004,31(4):734-743.DOI:10.1118/1.1645678.
[4] Guerrero M,Li XA,Ma LJ,et al. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer:radiobiological and dosimetric considerations[J].Int J Radiat Oncol Biol Phys,2005,62(3):933-939.DOI:10.1016/j.ijrobp.2004.11.040.
[5] Mollà M,Escude L,Nouet P,et al. Fractionated stereotactic radiotherapy boost for gynecologic tumors:an alternative to brachytherapy?[J].Int J Radiat Oncol Biol Phys,2005,62(1):118-124.DOI:10.1016/j.ijrobp.2004.09.028.
[6] Aydogan B,Mundt AJ,Smith BD,et al. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients[J].Int J Radiat Oncol Biol Phys,2006,65(1):266-273.DOI:10.1016/j.ijrobp.2005.12.049.
[7] Dimopoulos JCA,Kirisits C,Petric P,et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer:clinical feasibility and preliminary results[J].Int J Radiat Oncol Biol Phys,2006,66(1):83-90.DOI:10.1016/j.ijrobp.2006.04.041.
[8] Kirisits C,Lang S,Dimopoulos J,et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer:design,application,treatment planning,and dosimetric results[J].Int J Radiat Oncol Biol Phys,2006,65(2):624-630.DOI:10.1016/j.ijrobp.2006.01.036.
[9] Georg D,Kirisits C,Hillbrand M,et al. Image-guided radiotherapy for cervix cancer:high-tech external beam therapy versus high-tech brachytherapy[J].Int J Radiat Oncol Biol Phys,2008,71(4):1272-1278.DOI:10.1016/j.ijrobp.2008.03.032.
[10] Barillot I,Horiot JC,Maingon P,et al. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas:BASELINE results to compare new strategies[J].Int J Radiat Oncol Biol Phys,2000,48(1):189-200.DOI:10.1016/S0360-3016(00)00556-3.
[11] Cengiz M,Dogan A,Ozyigit G,et al. Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer[J].Brachytherapy,2012,11(2):125-129.DOI:10.1016/j.brachy.2011.12.001.
[12] Marnitz S,Köhler C,Budach V,et al. Brachytherapy-emulating robotic radiosurgery in patients with cervical carcinoma[J].Radiat Oncol,2013,8:109.DOI:10.1186/1748-717X-8-109.
[13] Kubicek GJ,Xue JY,Xu QY,et al. Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic cancer[J].BioMed Res Int,2013,2013:898953.DOI:10.1155/2013/898953.
[14] Haas JA,Witten MR,Clancey O,et al. CyberKnife boost for patients with cervical cancer unable to undergo brachytherapy[J].Front Oncol,2012,2:25.DOI:10.3389/fonc.2012.00025.
[15] Mundt AJ,Roeske JC.Can intensity-modulated radiation therapy replace brachytherapy in the management of cervical cancer?[J].Brachytherapy,2002,1(4):192-194.DOI:10.1016/S1538-4721(03)00002-3.
[16] Gill BS,Lin JF,Krivak TC,et al. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer:the impact of new technological advancements[J].Int J Radiat Oncol Biol Phys,2014,90(5):1083-1090.DOI:10.1016/j.ijrobp.2014.07.017.
[17] Tanderup K,Eifel PJ,Yashar CM,et al. Curative radiation therapy for locally advanced cervical cancer:brachytherapy is NOT optional[J].Int J Radiat Oncol Biol Phys,2014,88(3):537-539.DOI:10.1016/j.ijrobp.2013.11.011.
[18] Tanderup K,Georg D,Pötter R,et al. Adaptive management of cervical cancer radiotherapy[J].Semin Radiat Oncol,2010,20(2):121-129.DOI:10.1016/j.semradonc.2009.11.006.
[19] Lindegaard JC,Tanderup K.Counterpoint:time to retire the parametrial boost[J].Brachytherapy,2012,11(2):80-83.DOI:10.1016/j.brachy.2012.01.004.
[20] Good J,Lalondrelle S,Blake P.Point:parametrial irradiation in locally advanced cervix cancer can be achieved effectively with a variety of external beam techniques[J].Brachytherapy,2012,11(2):77-79.DOI:10.1016/j.brachy.2012.01.003.
[21] Duan J,Kim RY,Elassal S,et al. Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost:a novel approach for improving cervical tumor dose coverage[J].Int J Radiat Oncol Biol Phys,2008,71(3):765-771.DOI:10.1016/j.ijrobp.2007.10.064.
[22] Assenholt MS,Petersen JB,Nielsen SK,et al. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer[J].Acta Oncol,2008,47(7):1337-1343.DOI:10.1080/02841860802266698.
[23] Assenholt MS,Vestergaard A,Kallehauge JF,et al. Proof of principle:applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer[J].Brachytherapy,2014,13(4):361-368.DOI:10.1016/j.brachy.2014.02.003.
[24] Yin G,Wang P,Lang JY,et al. Dosimetric study for cervix carcinoma treatment using intensity modulated radiation therapy (IMRT) compensation based on 3D intracavitary brachytherapy technique[J].J Contemp Brachytherapy,2016,8(3):221-232.DOI:10.5114/jcb.2016.60590.